Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):191-198. doi: 10.1111/bcpt.12903. Epub 2017 Nov 28.
The pattern recognition formyl peptide receptors (FPRs) belong to the class of G-protein-coupled receptors (GPCRs), the largest group of cell surface receptors involved in a range of physiological processes and pathologies. The FPRs have regulatory function in the initiation as well as resolution of inflammatory reactions, making them highly interesting as targets for drug development. Recent research in the GPCR/FPR fields has uncovered novel receptor biology concepts, including biased signalling/functional selectivity, allosteric modulation, receptor reactivation and receptor cross-talk. When it comes to allosteric modulators, 'tailor-made' lipopeptides (pepducins and lipopeptoids) represent a novel concept of GPCR/FPR regulation. This MiniReview is focused on the basis for recognition of conventional ligands and immunomodulating lipopeptides, novel allosteric modulators for the FPRs, receptors that are highly expressed by both human and mouse neutrophils. The FPRs play key roles in host defence against microbial infections, tissue homeostasis and the initiation as well as resolution of inflammation but there are both similarities and differences in ligand recognition between mice and men. Thus, identification and functional characterization of activating and inhibiting ligands should provide insights into future design of FPR-based animal models of human diseases and development of therapeutics for treating inflammatory diseases.
模式识别甲酰肽受体(FPRs)属于 G 蛋白偶联受体(GPCRs)家族,GPCRs 是参与多种生理过程和病理的最大细胞表面受体群之一。FPRs 在炎症反应的启动和解决中具有调节功能,使其成为药物开发的极具吸引力的靶点。最近在 GPCR/FPR 领域的研究揭示了新的受体生物学概念,包括偏向信号/功能选择性、变构调节、受体再激活和受体串扰。当涉及变构调节剂时,“定制”的脂肽(pepducin 和脂肽)代表了 GPCR/FPR 调节的新概念。这篇 MiniReview 专注于识别传统配体和免疫调节脂肽的基础,新型 FPR 变构调节剂,这些调节剂在人和小鼠中性粒细胞中高度表达。FPRs 在宿主抵御微生物感染、组织动态平衡以及炎症的启动和解决中发挥关键作用,但小鼠和人类在配体识别方面既有相似之处,也有不同之处。因此,激活和抑制配体的鉴定和功能表征应能深入了解基于 FPR 的人类疾病动物模型的未来设计和治疗炎症性疾病的治疗方法的发展。